KM-3060

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameKM-3060
Drug Alias NameKM-3060
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 4 antagonists
TargetsC-C chemokine receptor type 4
Therapy Area/IndicationsLeukemia-Lymphoma, Adult T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Kirin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Kirin
Active IndicationsN/A
Inactive IndicationsLeukemia-Lymphoma, Adult T-Cell

Other Information

ATC CodeN/A
Related LinksN/A